oprah and semaglutide In the Spotlight: Oprah's Weight Loss Transformation Oprah Winfrey Weight Loss: Star

Semaglutide (Rybelsus

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

While the absolute risk increase was modest, our findings point to an important potential adverse effect that clinicians should consider, especially in patients with predisposing factors for GERD

Although the higher dose showed modest within-group weight reduction and improved HbA1c, unexpectedly substantial placebo-associated weight loss limited the observed treatment effect.

Nooms new Microdose GLP-1Rx Program could be a game changer by leveraging low-dose compounded semaglutide with clinical coaching to reduce side effects and cut costs

But a new study finds the majority of people who use these drugs quit after just two years